T Cell News and Research

Latest T Cell News and Research

Study reveals new therapeutic options for multiple sclerosis

Multiple sclerosis is known as "the disease with a thousand faces" because symptoms and progression can vary dramatically from patient to patient.

20 Apr 2020

EMBL researchers create ‘virtual embryo’ for single-cell studies

Researchers from EMBL Heidelberg and from the University of Padua School of Medicine have created the first complete description of early embryo development, accounting for every single cell in the embryo.

20 Apr 2020

A new combinatorial therapy for treatment of liver cancer

In the latest issue of Molecular Therapy, Skoltech and MIT researchers have published a new combinatorial therapy for the treatment of liver cancer.

20 Apr 2020

Research pinpoints potential new therapeutic target for retinal degeneration

Multi-disciplinary work led by researchers from Trinity College Dublin has pinpointed a potential new therapeutic target for treating retinal degeneration. The work has discovered that a protein (SARM1) involved in neuronal cell injury may also have a role in the progression of retinal degeneration.

20 Apr 2020

Activating a braking mechanism against cancer

A team has identified the binding site where drug compounds could activate a braking mechanism against runaway growth of cancer.

20 Apr 2020

Potential new therapies for multiple sclerosis

In every MS patient cells of their body's own immune system migrate to the brain, where they destroy the myelin sheath.

20 Apr 2020

Research will drastically stabilize brain-computer interfaces

Researchers have drastically improve brain-computer interfaces and their ability to remain stabilized during use.

20 Apr 2020

FAU scientists win $1.7 million NIH grant for research on neuroinflammation

Anxiety, depression and cognitive decline are prominent psychopathologies that together affect more than 40 million people in the United States.

20 Apr 2020

Study adds increasing evidence that autoimmunity plays a role in Parkinson's disease

A new study co-led by scientists at the La Jolla Institute for Immunology adds increasing evidence that Parkinson's disease is partly an autoimmune disease. In fact, the researchers report that signs of autoimmunity can appear in Parkinson's disease patients years before their official diagnosis.

20 Apr 2020

New high-throughput approach yields libraries of probes for immunological assays

An immunological test known as a "tetramer assay" can detect T cells in a blood sample that recognize a specific antigen.

20 Apr 2020

New research gives further evidence that autoimmunity plays a role in Parkinson's disease

A new study adds increasing evidence that Parkinson's disease is partly an autoimmune disease.

20 Apr 2020

Remdesivir prevents COVID-19 progression to severe pneumonia, animal study shows

A team of scientists at the National Institute of Allergy and Infectious Diseases, which is part of the U.S. National Institutes of Health, has tested the efficacy of remdesivir, a nucleotide analog prodrug with a broad antiviral activity, as a COVID-19 treatment.

20 Apr 2020

Novel coronavirus mutation could spell trouble for vaccine development

New research shows that the novel coronavirus is undergoing mutations that could make it challenging to develop a vaccine against. There are a few vaccine candidates that are in the making to prevent COVID-19. With a potential for mutation, the vaccines that are being developed now may not work against the emergent mutated strains worry Taiwanese and Australian researchers. The study is titled, “Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of 2 RBD mutant with lower ACE2 binding affinity.”

19 Apr 2020

Research suggests Nelfinavir and Cepharanthine as potential anti-SARS-CoV-2 agents

A new study published in the journal bioRxiv in April 2020 reports the identification of a promising multidrug treatment against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for causing COVID-19 disease. The team predicts that this combination will prevent the virus from reproducing, hence both halting the transmission and progress of the disease.

19 Apr 2020

T Cell News and Research

Latest T Cell News and Research

Study reveals new therapeutic options for multiple sclerosis

EMBL researchers create ‘virtual embryo’ for single-cell studies

A new combinatorial therapy for treatment of liver cancer

Research pinpoints potential new therapeutic target for retinal degeneration

Activating a braking mechanism against cancer

Potential new therapies for multiple sclerosis

Research will drastically stabilize brain-computer interfaces

FAU scientists win $1.7 million NIH grant for research on neuroinflammation

Study adds increasing evidence that autoimmunity plays a role in Parkinson's disease

New high-throughput approach yields libraries of probes for immunological assays

New research gives further evidence that autoimmunity plays a role in Parkinson's disease

Remdesivir prevents COVID-19 progression to severe pneumonia, animal study shows

Novel coronavirus mutation could spell trouble for vaccine development

Research suggests Nelfinavir and Cepharanthine as potential anti-SARS-CoV-2 agents

Computer simulations yield promising vaccine candidate against SARS-CoV-2

Salk scientists uncover surprising role of tuft cells in pancreatitis

Study describes unconventional mechanism of ionic channel traffic in cardiac cells

Embryonic stem cells commit to specialization surprisingly early

New study raises red flags about strategy to block cancer drug resistance

Study identifies two new viruses in Brazilian patients with suspected dengue

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in